The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia
Patients with CRS/ICANS experience similar clinical outcomes compared with those without CRS/ICANS following anti-CD19 CAR-T therapy.
Authors
- Yongxian Hu (ORCID: https://orcid.org/0009-0009-9154-0072)
- Bingpei Zhang
- Qing Zhang (ORCID: https://orcid.org/0000-0001-7941-4318)
- Ruiyang Xie (ORCID: https://orcid.org/0000-0002-9647-2218)
- Aibin Liang (ORCID: https://orcid.org/0000-0002-8978-1987)
- Jiaoli Zhang
- Keshu Zhou (ORCID: https://orcid.org/0000-0001-5467-1377)
- Xiangmin Wang (ORCID: https://orcid.org/0000-0002-3639-7228)
- Ziyuan Shen (ORCID: https://orcid.org/0000-0001-6989-9147)
- Yujie Li (ORCID: https://orcid.org/0000-0002-6249-2237)
- Ping Li (ORCID: https://orcid.org/0000-0001-5480-3755)
- Kailin Xu (ORCID: https://orcid.org/0000-0003-1375-1084)
- Lu Han (ORCID: https://orcid.org/0000-0002-9004-4458)
- Yuhan Ma (ORCID: https://orcid.org/0009-0001-4495-0054)
- Hongyuan Zhou (ORCID: https://orcid.org/0000-0003-0682-6295)
- Wei Sang
Institutions
- Tongji University (CN)
- Xuzhou Medical College (CN)
- Anhui Medical University (CN)
- Zhengzhou University (CN)
- Suizhou Central Hospital (CN)
- Tongji Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3389/fimmu.2024.1448709
- Citations
- 8
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 2.26
Funders
- Government of Jiangsu Province
- Tongji University
- Zhengzhou University
- Natural Science Foundation of Jiangsu Province
- Zhejiang University
- Jiangsu Science and Technology Department
- Xuzhou Medical University